On locally graded barely transitive groups
Abstract We show that a barely transitive group is totally imprimitive if and only if it is locally graded. Moreover, we obtain the description of a barely transitive group G for the case G has a cyclic subgroup 〈x〉 which intersects non-trivially with all subgroups and for the case a point stabilizer H of G has a subgroup H
Mahmut Kuzucuoğlu
exaly +5 more sources
Locally graded groups with all non-nilpotent subgroups permutable
Let $G$ be a locally graded group and suppose that every non-nilpotent subgroup of $G$ is permutable. We prove that $G$ is soluble. (In light of previous results of the authors, it suffices to prove that $G$ is soluble if it is periodic.
Martyn Dixon, Martin Evans
exaly +8 more sources
Locally graded groups with a condition on infinite subsets [PDF]
Let $G$ be a group, we say that $G$ satisfies the property $mathcal{T}(infty)$ provided that, every infinite set of elements of $G$ contains elements $xneq y, z$ such that $[x, y, z]=1=[y, z, x]=[z, x, y]$.
Asadollah Faramarzi Salles +1 more
doaj +5 more sources
Efficacy and safety of neoadjuvant treatment with PD-1 inhibitor in locally advanced head and neck squamous cell carcinoma [PDF]
Head and neck squamous cell carcinoma (HNSCC) is a common malignant tumor. Traditional treatments have unstable efficacy, with risks of relapse, drug resistance and side effects.
Shaowei Xu +5 more
doaj +2 more sources
Toripalimab plus disitamab vedotin versus tislelizumab-based combination in advanced urothelial carcinoma: a real-world comparative study [PDF]
Background The optimal PD-1 inhibitor to combine with disitamab vedotin in advanced urothelial carcinoma remains unclear. This study aimed to compare the real-world efficacy and safety of toripalimab plus disitamab vedotin versus tislelizumab plus ...
Tianwei Wang, Xi Jiang
doaj +2 more sources
Efficacy and safety of neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in locally advanced resectable esophageal squamous cell carcinoma [PDF]
Objective To compare the efficacy and safety of neoadjuvant chemoradiotherapy (NCRT) versus chemoimmunotherapy (NCIT) in resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC).
Yuanyuan Jiang +4 more
doaj +2 more sources
On difficult problems and locally graded groups
A group \(G\) is called an LG-group if any non-trivial finitely generated subgroup in \(G\) has a proper subgroup of finite index. It is known that the class of LG-groups is closed with respect to taking subgroups, extensions and Cartesian products. This class also contains all groups whose finitely generated subgroups are LG-groups and all groups that
O Macedońska
exaly +4 more sources
Alternate to soybean meal: evaluation of guar korma on growth performance, nutrient utilization and blood biochemical indices in water buffalo (Bubalus bubalis) calves [PDF]
IntroductionSoybean meal is a high protein, one of the major feed ingredients used in calf ration. However, high cost and limited availability restricts its application in practical ration formulation.
Avijit Dey +6 more
doaj +2 more sources
Groups whose Proper Subgroups of Infinite Rank are Černikov-by-Hypercentral or Hypercentral-by-Černikov [PDF]
It is proved that if G is an X-group of infinite rank whose proper subgroups of infinite rank are Černikov-by-hypercentral, respectively hypercentral-by-Černikov, then all proper subgroups of G are Černikov-by-hypercentral, respectively hypercentral-by ...
Amel Zitouni, Nadir Trabelsi
doaj +1 more source
On some generalization of the malnormal subgroups [PDF]
A subgroup $H$ of a group $G$ is called malonormal in $G$ if $H \cap H^x =\langle 1\rangle$ for every element $x \notin N_G(H)$. These subgroups are generalizations of malnormal subgroups.
Leonid Kurdachenko +2 more
doaj +1 more source

